4,9-Dibromo-6,7-dimethyl[1,2,5]thiadiazolo[3,4-g]quinoxaline(CAS: 851486-39-0)

4,9-Dibromo-6,7-dimethyl[1,2,5]thiadiazolo[3,4-g]quinoxaline (CAS: 851486-39-0) falls under the regulatory guidelines of the REACH regulation for chemicals in the European Union. It also adheres to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. For the United States, it meets FDA and EPA requirements for chemical safety and environmental protection.

In synthesis, alternatives to 4,9-Dibromo-6,7-dimethyl[1,2,5]thiadiazolo[3,4-g]quinoxaline include other brominated quinoxaline derivatives or thiadiazole-based compounds. Common reagents used as substitutes include 2,3-dibromothiadiazole and 6,7-dimethylquinoxaline. These alternatives offer similar functionalities but may vary in reactivity and availability.

The market and research trends for 4,9-Dibromo-6,7-dimethyl[1,2,5]thiadiazolo[3,4-g]quinoxaline (CAS: 851486-39-0) are focused on its applications in pharmaceuticals and materials science. Recent research highlights its potential in antiviral and anticancer drug development. Market trends indicate increasing demand due to its unique chemical properties, driving further exploration and innovation in synthetic chemistry.

Waste containing 4,9-Dibromo-6,7-dimethyl[1,2,5]thiadiazolo[3,4-g]quinoxaline (CAS: 851486-39-0) should be handled by first neutralizing any acidic or basic components. Subsequently, it should be collected in a proper container and disposed of through a professional waste disposal service to ensure environmental safety. Safety precautions include proper ventilation and the use of personal protective equipment (PPE) during handling and disposal processes.